RegentAtlantic Capital’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,916
Closed -$214K 673
2022
Q2
$214K Hold
8,916
0.01% 625
2022
Q1
$272K Buy
8,916
+1,646
+23% +$49.2K 0.01% 590
2021
Q4
$237K Sell
7,270
-3,405
-32% -$108K 0.01% 630
2021
Q3
$308K Buy
10,675
+2,143
+25% +$62.6K 0.01% 552
2021
Q2
$234K Sell
8,532
-289
-3% -$7.4K 0.01% 589
2021
Q1
$210K Buy
+8,821
New +$197K 0.01% 527
2020
Q1
Sell
-12,752
Closed -$263K 423
2019
Q4
$263K Buy
12,752
+353
+3% +$7.04K 0.02% 405
2019
Q3
$235K Sell
12,399
-1,362
-10% -$24.7K 0.02% 397
2019
Q2
$235K Hold
13,761
0.02% 395
2019
Q1
$229K Buy
+13,761
New +$214K 0.02% 400

Other funds holding BN

RegentAtlantic Capital's BN Position: Q3 2022 in Review

RegentAtlantic Capital sold out of Brookfield (BN) in Q3 2022, closing a stake of 8,916 shares — an estimated $214K sold.

RegentAtlantic Capital first reported a position in BN in Q1 2019 and held it in 10 quarters. The position peaked at $308K in Q3 2021. 688 funds tracked by Wall St. Rank hold BN as of Q3 2022.

  • RegentAtlantic Capital reported no remaining Brookfield position as of Q3 2022 after selling out during the quarter.
  • RegentAtlantic Capital sold 8,916 Brookfield shares in Q3 2022, an estimated $214K.
  • RegentAtlantic Capital first reported a position in Brookfield in Q1 2019 and held it in 10 quarters.
  • RegentAtlantic Capital's Brookfield position peaked at $308K in Q3 2021.
  • 688 funds tracked by Wall St. Rank held Brookfield as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.